Covered recipient · General Payments record
DAVID A MCCALL
Allopathic & Osteopathic Physicians Orthopaedic Surgery
General Payments · PY2018–2023
$536.15
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $386.15 | 19 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $149.70 | 10 |
| Lilly USA, LLC | $138.16 | 4 |
| PFIZER INC. | $40.50 | 2 |
| GlaxoSmithKline, LLC. | $23.61 | 1 |
| DEXCOM, INC. | $20.18 | 1 |
| Abbott Laboratories | $14.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $14.00 | 05/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018946575 | CMS |
| Dexcom, Inc. | $20.18 | 06/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054612537 | CMS |
| GlaxoSmithKline, LLC. | $23.61 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000896357 | CMS |
| Lilly USA, LLC | $23.42 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031435469 | CMS |
| Lilly USA, LLC | $14.60 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031352387 | CMS |
| Lilly USA, LLC | $82.62 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031323391 | CMS |
| Lilly USA, LLC | $17.52 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031452421 | CMS |
| Novo Nordisk Inc | $8.77 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000541 | CMS |
| Novo Nordisk Inc | $24.12 | 04/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000615 | CMS |
| Novo Nordisk Inc | $7.13 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000519 | CMS |
| Novo Nordisk Inc | $22.98 | 04/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000601 | CMS |
| Novo Nordisk Inc | $16.14 | 04/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000565 | CMS |
| Novo Nordisk Inc | $8.16 | 04/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000529 | CMS |
| Novo Nordisk Inc | $22.83 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000589 | CMS |
| Novo Nordisk Inc | $16.89 | 05/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000577 | CMS |
| Novo Nordisk Inc | $15.71 | 05/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000553 | CMS |
| Novo Nordisk Inc | $6.97 | 05/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003000507 | CMS |
| PFIZER INC. | $16.85 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050630407 | CMS |
| PFIZER INC. | $23.65 | 05/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050459059 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2023
- Source files
- Dataset page · Bulk file · PY2018 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.